Safety and preliminary efficacy of vorinostat with R-EPOCH in high-risk HIV-associated non-Hodgkin's lymphoma (AMC-075)

Authors

Juan C. Ramos, University of Miami
Joseph A. Sparano, Albert Einstein College of Medicine
Michelle A. Rudek, Johns Hopkins School of Medicine
Page C. Moore, University of Arkansas for Medical Sciences
Ethel Cesarman, Weill Cornell Medicine
Erin G. Reid, University of California San Diego
David Henry, Pennsylvania Hospital
Lee Ratner, Washington University School of Medicine in St. Louis
David Aboulafia, University of Washington
Jeanette Y. Lee, University of Arkansas for Medical Sciences
Richard F. Ambinder, Johns Hopkins School of Medicine
Ronald Mitsuyasu, David Geffen School of Medicine
Ariela Noy, Weill Cornell Medical College

Journal

Clinical Lymphoma Myeloma and Leukemia

Publication Date

2018

Volume

18

Issue

3

Inclusive Pages

180-190.e2

Document Type

Open Access Publication

DOI

10.1016/j.clml.2018.01.004

Rights and Permissions

Ramos JC, Sparano JA, Rudek MA, et al (2018) Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical Lymphoma Myeloma and Leukemia, 18(3):180-190.e2 https://doi.org/10.1016/j.clml.2018.01.004 Copyright 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). https://doi.org/10.1016/j.clml.2018.01.004

Recommended Citation

Ramos, Juan C.; Sparano, Joseph A.; Rudek, Michelle A.; Moore, Page C.; Cesarman, Ethel; Reid, Erin G.; Henry, David; Ratner, Lee; Aboulafia, David; Lee, Jeanette Y.; Ambinder, Richard F.; Mitsuyasu, Ronald; and Noy, Ariela, "Safety and preliminary efficacy of vorinostat with R-EPOCH in high-risk HIV-associated non-Hodgkin's lymphoma (AMC-075)." Clinical Lymphoma Myeloma and Leukemia. 18, 3. 180-190.e2. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6717